[Slow progress in therapy of breast carcinoma].
Aumiller
Jochen
J
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D006801:Humans; D008197:Lymph Node Excision; D015412:Mastectomy, Segmental; D010919:Placebos; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D021701:Sentinel Lymph Node Biopsy; D015398:Signal Transduction; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D010919:Placebos; D013629:Tamoxifen